TargetMol

Droprenilamine

Product Code:
 
TAR-T31577
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31577-1mg1mg£370.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31577-5mg5mg£790.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31577-10mg10mg£1,058.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31577-25mg25mg£1,532.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31577-50mg50mg£2,038.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31577-100mg100mg£2,713.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Droprenilamine is a biochemical.
CAS:
57653-27-7
Formula:
C24H33N
Molecular Weight:
335.535
Purity:
0.98
SMILES:
C[C@H](CC1CCCCC1)NCCC(c1ccccc1)c1ccccc1

References

1. Nakanishi H, Matsuoka I, Ono T, Yoshida H, Uchibori T, Kogi K. Effect of a prenylamine analog (MG8926) on spontaneous action potentials in isolated rabbit sinoatrial node. Fukushima J Med Sci. 1996 Dec;42(1-2):1-10. PubMed PMID: 9127964. 2. Baratta L, Mastrocola C, Lanciotti G, Petrosillo N, Tubani L, Iannetti A, Avella A. [Comparison of 2 groups of patients with ischemic cardiopathy treated with droprenylamine and prenylamine]. Minerva Cardioangiol. 1982 Jun;30(6):299-302. Italian. PubMed PMID: 7133418. 3. Rengo F, Trimarco B, Volpe M, Ricciadelli B, Morrone G, De Simone A, Condorelli M. [Clinical evaluation of a new antianginal drug: droprenylamine]. G Ital Cardiol. 1980;10(4):473-5. Italian. PubMed PMID: 7002693. 4. Baratta L, Mastrocola C, Petrosillo N, Guerrieri P, Leone G, Lanciotti G. [Clinical and electrocardiographic evaluation of the effectiveness of droprenylamine in patients with ischemic cardiopathy]. Minerva Cardioangiol. 1979 Nov;27(11):709-18. Italian. PubMed PMID: 545178.